Autoimmune Disease Diagnostics Market size worth $15bn by 2023

1
Autoimmune Disease Diagnostics Market size worth
15bn by 2023 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Autoimmune Disease Diagnostics
Market

• Global autoimmune disease diagnostics market size
  was pegged at USD 12.8 billion in 2015, and
  projected to reach USD 15.7 billion by 2023, at
  an estimated CAGR of 2.6 from 2016 to 2023.
• Europe autoimmune disease diagnostics industry
  should show steady growth, with Germany, and UK
  being key revenue contributors, with more than
  30 of total 2015 regional revenue. 
• Growing prevalence due to low awareness levels in
  Asia-Pacific should offer potential growth for
  the autoimmune disease diagnostics market. The
  region is slated to witness highest CAGR of 5.3
  from 2016 to 2023. China and Japan are the major
  revenue pockets.

3
Continued...

• With various small and local players competing on
  the basis of price, there is some degree of
  fragmentation on a domestic level. However, large
  capital expenditure is required in case of lab
  automation technology oriented manufacturing.
• Introduction of innovative technologically
  advanced products such as Celiac Panel Test by
  SQI Diagnostics that enables faster IgG IgA
  antibodies detection, and customized time saving,
  multifunctional kits such as ImmunoSEQtime should
  further contribute to the industry growth.

4
Autoimmune Disease Diagnostics Market Size, By
Product, 2012 - 2023 (USD Million)

5

Browse Full Market Research Report On
Autoimmune Disease Diagnostics Market _at_
http//goo.gl/So1hRc Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/618
6
360 Analysis

• Product Analysis
• Localized autoimmune disease diagnostics market
  size was the largest industry segment, with
  revenue reported to exceed USD 10 billion by
  2023. Factors such as rising prevalence of
  autoimmune disease, and increasing awareness
  among patients drive localized diagnostics
  demand.
• Regional Analysis
• U.S. autoimmune disease diagnostics market share
  was responsible for more than 60 of the USD 5.3
  billion valued North America region in 2015,
  driven by growing prevalence of autoimmune
  disorders, and growing trend of lab automation
  that provides rapid and accurate test results,
  increasing demand for portable diagnostic
  equipment.
• Competitive Market Share
• Global autoimmune disease diagnostics market
  share is undergoing rapid consolidation, and is
  marked by the presence of extensive mergers and
  acquisitions.  Major players compete on the basis
  of price, and introduction of new technologically
  improved diagnostic kits in the market. Large
  companies are investing in lab automation
  technology in order to maintain leadership
  position in the market.

7
Stay In Touch Website www.gminsights.com Soci
al Media